The global healthcare industry stands as a significant contributor to the planet’s carbon footprint, accounting for an estimated 4.4% of…
Read More
Paradigm Health Launches SPIRE Platform to Revolutionize Post-Approval Oncology Research
The landscape of oncology therapeutics is rapidly evolving, with groundbreaking treatments continuously emerging and receiving regulatory approval. However, the journey…
Read More
CVC Capital Partners and Groupe Bruxelles Lambert Launch $12.4 Billion Takeover Bid for Recordati, Signaling Potential Shift to Private Ownership
One of Italy’s few remaining publicly traded large pharmaceutical companies, Recordati, is on the cusp of transitioning to private ownership…
Read More
Q&A: How 3PLs are navigating the latest pharma trends – Pharmaceutical Technology
The pharmaceutical logistics landscape is undergoing a profound transformation, moving beyond the traditional "store and ship" model to embrace comprehensive…
Read More
Chinese firms landed 6 of 26 major pharma deals in 16 months, worth $53 billion
Over the past 16 months, Chinese-domiciled biotechnology companies have emerged as significant players in the global pharmaceutical landscape, securing approximately…
Read More
FUJIFILM Cellular Dynamics Inaugurates State-of-the-Art Induced Pluripotent Stem Cell Manufacturing Facility in Madison, Wisconsin
FUJIFILM Cellular Dynamics has officially opened its new headquarters and a cutting-edge induced pluripotent stem cell (iPSC) manufacturing facility in…
Read More
Gilead Sciences Pledges Over 400,000 Doses of AmBisome to Combat Visceral Leishmaniasis, Extending Vital Global Health Partnership
Gilead Sciences has announced a significant commitment to global health, pledging over 400,000 doses of its vital antifungal medication, AmBisome…
Read More
Eli Lilly Acquires Engage Biologics for Up to $202 Million, Bolstering Its Genetic Medicine Pipeline with Innovative Non-Viral DNA Delivery Technology
Pharmaceutical giant Eli Lilly and Company has announced its agreement to acquire Engage Biologics, a California-based biotechnology firm, for a…
Read More
Pharma R&D Returns Soar to 7% Driven Almost Exclusively by GLP-1 Therapies, Deloitte Report Reveals
The pharmaceutical industry, after a period characterized by uneven growth and post-pandemic recalibration, is witnessing a significant upturn in R&D…
Read More
Takeda Ordered to Pay $885 Million in Landmark "Pay-for-Delay" Drug Case, Faces Potential $2.5 Billion Liability
In a groundbreaking verdict that could reshape pharmaceutical antitrust litigation, a U.S. jury has found Japanese pharmaceutical giant Takeda liable…
Read More
